IBD
Inspire Corporate Bond Impact ETFIBD Fund Description
IBD tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards.
IBD Factset Analytics Insight
IBD’s index utilizes a principles-based bond strategy that aligns with evangelical Christian values. Starting from a broad universe of USD-denominated, investment-grade corporate bonds issued by companies in the S&P 500 Index, IBD screens out companies with any participation in activities that are inconsistent with biblical values as defined by the index sponsor. The fund then applies a proprietary model to evaluate companies based on primary business activities, products and services, philanthropy, legal activities, policies and practices to generate Inspire Impact Scores. The fund holds 250 bonds from the 200 highest-scoring issuers, and equally weights them across four maturity tranches of 0-3, 3-5, 5-7, and 7-10 years, to arrive at an average maturity of approximately 5 years. Overall, IBD is a potential fit for investors who share the faith-based principles defined by IBD’s sponsor and want to invest accordingly.
IBD MSCI ESG Analytics Insight
Inspire Corporate Bond Impact ETF has an MSCI ESG Fund Rating of AA based on a score of 7.62 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Inspire Corporate Bond Impact ETF ranks in the 65th percentile within its peer group and in the 88th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
IBD Summary Data
IBD Portfolio Data
IBD Index Data
IBD Portfolio Management
IBD Tax Exposures
IBD Fund Structure
IBD Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of IBD. IBD is rated a N/A out of 5.
IBD Tradability
IBD Sector/Industry Breakdown
IBD
IBD Top 10 Holdings[View All]
IBD Top 5 Countries
IBD
IBD Top 5 Currencies
IBD
IBD Performance Statistics
IBD MSCI ESG Ratings
IBD Holdings Statistics
IBD Avg Life Maturity Distribution
IBD OAS Breakdown
The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.
ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.
[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
Data provider:
Terms of Use
MSCI ESG Research LLC’s ("MSCI ESG") Fund Metrics products (the "Information") provide environmental, social and governance data with respect to underlying securities within more than 24,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided "as is" and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.